1 Min Read
Nov 2 (Reuters) - Bioblast Pharma Ltd
* Bioblast Pharma reports third quarter 2017 financial results
* Q3 loss per share $0.32 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.